<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" href="https://www.taxtmi.com/rss_sitemap/rss_feed_blog.xsl?v=1750492856"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>2005 (9) TMI 581 - CESTAT, MUMBAI</title>
    <link>https://www.taxtmi.com/caselaws?id=120399</link>
    <description>Notification No. 245/83 was construed as not limiting excise exemption to medicines requiring compulsory price approval by drug authorities. The decisive condition was submission of the retail price to the drug authorities, and that requirement was satisfied even where formal approval was unnecessary. The goods accordingly fell within the notification, and the benefit of the 15% discount could not be denied on the ground that the medicines were outside the price-approval regime.</description>
    <language>en-us</language>
    <pubDate>Thu, 29 Sep 2005 00:00:00 +0530</pubDate>
    <lastBuildDate>Thu, 19 Jul 2012 10:50:34 +0530</lastBuildDate>
    <generator>TaxTMI RSS Generator</generator>
    <atom:link href="https://www.taxtmi.com/rss_feed_blog?id=157394" rel="self" type="application/rss+xml"/>
    <item>
      <title>2005 (9) TMI 581 - CESTAT, MUMBAI</title>
      <link>https://www.taxtmi.com/caselaws?id=120399</link>
      <description>Notification No. 245/83 was construed as not limiting excise exemption to medicines requiring compulsory price approval by drug authorities. The decisive condition was submission of the retail price to the drug authorities, and that requirement was satisfied even where formal approval was unnecessary. The goods accordingly fell within the notification, and the benefit of the 15% discount could not be denied on the ground that the medicines were outside the price-approval regime.</description>
      <category>Case-Laws</category>
      <law>Central Excise</law>
      <pubDate>Thu, 29 Sep 2005 00:00:00 +0530</pubDate>
      <guid isPermaLink="true">https://www.taxtmi.com/caselaws?id=120399</guid>
    </item>
  </channel>
</rss>